Rexall Faces Private Suits Over Cellasene

January 1, 2001

1 Min Read
Supply Side Supplement Journal logo in a gray background | Supply Side Supplement Journal

BOCA RATON, Fla.--Rexall Sundown Inc. was hit by another lawsuit regarding its anti-cellulite pill, Cellasene. Rose Carter of South Carolina filed the suit after spending approximately $119 on three boxes of Cellasene in 1999. In her suit, which adds to the growing number of private lawsuits against the company, she alleged that the product failed to rid her of cellulite.

This suit follows the one filed in July by the Federal Trade Commission (FTC) that stated the product used false and misleading advertising. FTC charged that Rexall made false claims in its advertising and labeling of Cellasene, which contains ginkgo biloba, grapeseed extract, bladderwrack and sweet clover as well as iodine, borage seed oil and fish oil. However, Rexall stated that the product increases the body's metabolic rate and improves circulation, thereby reducing fluids and trapped fat; the company still stands behind the efficacy of its product. Rexall is a wholly owned subsidiary of the Dutch company, Royal Numico, N.V., which also owns brands such as Met-Rx, GNC and Enrich. For more information, visit www.rexallsundown.com , www.numico.com or www.ftc.gov.

Subscribe for the latest consumer trends, trade news, nutrition science and regulatory updates in the supplement industry!
Join 37,000+ members. Yes, it's completely free.

You May Also Like